ACM
BCDA icon

AIGH Capital Management’s BioCardia BCDA Stock Holding History

AIGH Capital Management’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,943
Closed -$994K – 50
2023
Q1 		$994K Sell
33,943
-5,739
-14% -$191K 0.37% 45
2022
Q4 		$1.24M Buy
+39,682
New +$1.13M 0.41% 39

Other funds holding BCDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
FM
Family Management New York $834M AUM 20.83% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

AIGH Capital Management's BCDA Position: Q2 2023 in Review

AIGH Capital Management sold out of BioCardia (BCDA) in Q2 2023, closing a stake of 33,943 shares — an estimated $994K sold.

AIGH Capital Management first reported a position in BCDA in Q4 2022 and held it in 2 quarters. The position peaked at $1.24M in Q4 2022. 23 funds tracked by Wall St. Rank hold BCDA as of Q2 2023.

  • AIGH Capital Management reported no remaining BioCardia position as of Q2 2023 after selling out during the quarter.
  • AIGH Capital Management sold 33,943 BioCardia shares in Q2 2023, an estimated $994K.
  • AIGH Capital Management first reported a position in BioCardia in Q4 2022 and held it in 2 quarters.
  • AIGH Capital Management's BioCardia position peaked at $1.24M in Q4 2022.
  • 23 funds tracked by Wall St. Rank held BioCardia as of Q2 2023.

Based on AIGH Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.